Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189304 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Safety Study of PT010 in Healthy Subjects
A Phase 1 study, sponsored by Pearl Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT02189304 is a Phase 1 study that has completed, run by Pearl Therapeutics. The registered enrollment target is 59 participants.
The verdict
NCT02189304, a Phase 1 study, has completed, sponsored by Pearl Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
This is a single-center, Phase I, healthy adult subject study with a randomized, double blind, three period, three-treatment, cross-over design.
Interventions
- DRUG PT010
- DRUG PT009
- DRUG Symbicort Turbohaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2014-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189304
The ClinicalTrials.gov registry entry for NCT02189304 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pearl Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PT010 is the first listed.
NCT02189304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02189304 about?
NCT02189304 is a clinical study titled "Pharmacokinetics and Safety Study of PT010 in Healthy Subjects". This is a single-center, Phase I, healthy adult subject study with a randomized, double blind, three period, three-treatment, cross-over design.
What is the current status of trial NCT02189304?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2014-06-01. Estimated completion is 2014-09-01.
What interventions are being tested in trial NCT02189304?
The interventions under investigation include: PT010 (DRUG), PT009 (DRUG), Symbicort Turbohaler (DRUG).
Who is sponsoring clinical trial NCT02189304?
This trial is sponsored by Pearl Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.